News

FDA approves Novavax's Covid-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.
MedPage Today6h
FDA Approves Novavax COVID-19 Shot, but With Unusual Restrictions
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions
The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable ...
STAT2h
Novavax wins narrowed approval for its Covid-19 shot after delay
Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.
TipRanks on MSN6h
FDA approves Novavax COVID-19 vaccine with restrictions
COVID-19 vaccine in a letter to the company dated Friday. “Under this license, you are authorized to manufacture ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the mRNA vaccines from ...
MySuncoast.com on MSN2h
New Novavax Covid -19 vaccine tailored for patients 65 and older
After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based covid vaccine produced by pharmaceutical giant Novavax.